BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2945926)

  • 1. Depo-Provera in the treatment of recurrent vulvovaginal candidiasis.
    Dennerstein GJ
    J Reprod Med; 1986 Sep; 31(9):801-3. PubMed ID: 2945926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depo-Provera use in an Australian metropolitan practice.
    Fraser IS; Dennerstein GJ
    Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term contraception with Depo-Provera: a clinical evaluation.
    Mukherjea M; Mukherjee P; Biswas R
    Int J Fertil; 1980; 25(2):122-6. PubMed ID: 6117526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depo-Provera in adolescents: effects of early second injection or prior oral contraception.
    Harel Z; Biro FM; Kollar LM
    J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medroxyprogesterone acetate as an injectable contraceptive.
    Heber KR
    Aust Fam Physician; 1988 Mar; 17(3):199-201, 204. PubMed ID: 2965570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective influence of progestogen only contraception against vaginal moniliasis.
    Toppozada M; Onsy FA; Fares E; Amir S; Shaala S
    Contraception; 1979 Aug; 20(2):99-103. PubMed ID: 487820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with the use of depo-medroxyprogesterone acetate in a Nigerian population.
    Falase EA; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1988 Dec; 17(4):209-13. PubMed ID: 2854367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depo provera in perspective.
    McGoldrick IA
    P N G Med J; 1981 Dec; 24(4):274-9. PubMed ID: 6461984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
    London RS
    J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception.
    Nelson AL
    J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of depo-provera in teens.
    Khoiny FE
    J Pediatr Health Care; 1996; 10(5):195-201. PubMed ID: 8920351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reply to Dr. Edwin B. McDaniel. Exaggerated claims of depo-provera safety.
    Minkin SF
    Women Health; 1981; 6(1-2):125-9. PubMed ID: 6223451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depo-Provera -- proving its innocence.
    Choudhury IR
    Indian Med Trib; 1994 Jul; 2(11):5. PubMed ID: 12179187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depot medroxyprogesterone acetate contraception in women with medical problems.
    Frederiksen MC
    J Reprod Med; 1996 May; 41(5 Suppl):414-8. PubMed ID: 8725704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting injectable contraception with depot medroxyprogesterone acetate.
    Kaunitz AM
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1543-9. PubMed ID: 8178904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Researcher explains status of Depo Provera. [Answer to question of Marienetta Blackwell].
    Greenspan A
    Contracept Technol Update; 1981 Mar; 2(3):35-6. PubMed ID: 12337540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
    Kaunitz AM
    Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
    Polaneczky M; Guarnaccia M; Alon J; Wiley J
    Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
    Lobo RA; McCormick W; Singer F; Roy S
    Obstet Gynecol; 1984 Jan; 63(1):1-5. PubMed ID: 6318170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.